Nomme Linnaosa

Estonia

3 total trials

Filter these 3 trials by phase, condition, sponsor and more.

Open in Search →

OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial Ended recruitment

2022-501608-85-00 5 2023-05-09 Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
An Open-Label Extension Study to Evaluate Long Term Safety and Efficacy of Tildrakizumab in Patients with Psoriatic Arthritis. Ended recruitment

2022-501480-41-00 5 2023-04-06 Psoriatic Arthritis
A Phase 2b Study to Evaluate MORF-057 in Adults with Moderately to Severely Active UC Ended recruitment

2022-500953-17-00 4 2023-03-23 Moderately to severely active ulcerative colitis

Showing 1–3 of 3 trials